BPC-157 Supports Vascular and Neurological Repair One underappreciated hallmark of long COVID is endothelial dysfunction damage to the lining of blood vessels that impairs circulation, oxygenation, and tissue delivery.7 BPC-157 has demonstrated angiogenic (new blood vessel formation) effects in research models, upregulating VEGFR2 and promoting collateral circulation in ischemic tissue.8 This matters for two reasons: Cardiovascular symptoms (breathlessness, reduced exercise tolerance, tachycardia) may partly reflect impaired tissue oxygenation from vascular damage Neurological symptoms (brain fog, cognitive impairment) may similarly reflect reduced cerebral blood flow BPC-157's neuroprotective effects shown across models of traumatic brain injury, dopamine dysregulation, and serotonin syndrome also suggest value in supporting the neurotransmitter disruption many long COVID patients experience.9 BPC-157 Modulates Inflammation Without Immune Suppression This is critical
Quality & Verification 99% purity confirmed via LC-MS/MS Endotoxin-tested for laboratory suitability Independently verified Certificate of Analysis Tested in the USA Scientific Literature & Research ContextResearch involving NNMT inhibition highlights its role in metabolic regulation, NAD metabolism, and epigenetic signaling pathways: Kraus, D
By inhibiting this enzyme, 5-Amino-1MQ restores cellular NAD+ levels
BPC-157 (10mg) + TB-500 (10mg) $70.00 In stock Strength: 20 mg In stock BPC-157 + TB-500 BPC-157 + TB-500 combines two complementary research peptides that have become widely studied for their roles in tissue physiology, cellular communication, and regenerative biology
World Anti-Doping Agency WADA Prohibited List class S4.5 metabolic modulators (ERR agonists as a class)
